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Summary
 
The mannose receptor (MR) has established roles in macrophage (M
 
f
 
) phagocytosis of micro-
organisms and endocytic clearance of host-derived glycoproteins, and has recently been impli-
cated in antigen capture by dendritic cells (DCs) in vitro. MR is the founder member of a fam-
ily of homologous proteins, and its recognition properties differ according to its tissue of origin.
Given this heterogeneity and our recent discovery of a soluble form of MR in mouse serum,
we studied the sites of synthesis of MR mRNA and expression of MR protein in normal mouse
tissues. We demonstrate that synthesis and expression occur at identical sites, and that mature
M
 
f
 
 and endothelium are heterogeneous with respect to MR expression, additionally describing
MR on perivascular microglia and glomerular mesangial cells. However, MR was not detected
on DCs
 
 
 
in situ, or on marginal zone or subcapsular sinus M
 
f
 
, both of which have MR-like
binding activities. We also compared expression of MR to the binding of a recombinant probe
containing the cysteine-rich domain of MR. We show that MR and its putative ligand(s) are
expressed at nonoverlapping sites within lymphoid organs, consistent with a transfer function
for soluble MR. Therefore, in addition to endocytic and phagocytic roles, MR may play an
important role in antigen recognition and transport within lymphoid organs.
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T
 
he mannose receptor (MR)
 
1
 
 was first identified as a
specific uptake system in rat liver Kupffer cells for
mannosylated/
 
N
 
-acetylglucosamine–terminal and fucosylated
neoglycoproteins in vivo (1). Later studies demonstrated
similar carbohydrate-specific binding by hepatic endothe-
lium (2), alveolar macrophages (M
 
f
 
) (3), resident and elic-
ited peritoneal M
 
f
 
 (4), human monocyte–derived M
 
f
 
 (5),
and cultured bone marrow–derived M
 
f
 
 (6). These were
attributed to the MR by Ab reactivity in Western blots of
purified receptor. MR has also been purified from human
retinal pigment epithelium (7). M
 
f
 
 expression of MR ap-
pears restricted to mature populations, is downregulated
during classical activation, such as in response to IFN-
 
g
 
 (8),
and is upregulated during an alternative form of activation
by IL-4 characterized by enhanced MHC class II (MHCII)
expression and reduced proinflammatory cytokine produc-
tion (9). More recently, MR has been detected on cultured
human dendritic cells (DCs) matured from CD14
 
1
 
 periph-
eral blood monocytes (10) and cord blood CD34
 
1
 
 hemo-
poietic progenitors with GM-CSF and IL-4 (11), although
it is not known how closely these cells reflect the properties
of DCs
 
 
 
in situ. Freshly isolated murine Langerhans cells
do not appear to express MR protein, although uptake of
mannose-BSA and a mannan-inhibitable component of zy-
mosan phagocytosis have been documented (12). In con-
trast, functional MR has been detected on freshly isolated
human Langerhans cells (13). Uncharacterized receptors
with similar binding activity to MR have been detected in
lymph node subcapsular sinus M
 
f
 
 of mouse (14) and rat (15)
and splenic marginal zone M
 
f
 
 of mouse (16) and rat (15).
The early studies on liver and mature M
 
f
 
 suggested two
 
1
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major functions for MR, in endocytic clearance of host-
derived glycoproteins and phagocytosis/endocytosis of mi-
croorganisms and soluble ligands, and evidence has accrued
in support of both roles. MR mediates uptake of ligands for
the purposes of both homeostasis and immunity. Homeo-
static functions include uptake of tissue plasminogen activa-
tor (17, 18) and lysosomal hydrolases (3). MR also plays a
major role in host defence. It is now widely accepted that
the recognition and phagocytosis of many nonopsonized
microorganisms, including bacteria, fungi, and protozoa by
M
 
f
 
, is mediated by MR, through interactions with poly-
saccharide components of fungal cell walls such as yeast
mannan, bacterial capsules, and some strains of LPS and li-
poarabinomannan (19). Transfection of nonphagocytic COS
cells with MR cDNA is sufficient to confer an ability to
recognize and phagocytose 
 
Candida albicans
 
 (20) and 
 
Pneu-
mocystis carinii
 
 (21). Ligation of MR in M
 
f
 
 causes intracel-
lular signaling resulting in functional changes, including
increased superoxide anion release (22) and induction of
cytokine synthesis (23). The immunological roles of MR
may extend to specific immunity if the observed MR-
mediated uptake of glycoconjugates by cultured human
DCs for efficient presentation to T cells by MHCII (24–26)
and CD1b (27) prove to have in vivo correlates.
At a biochemical level, polysaccharide recognition has
been attributed to cooperative, calcium-dependent binding
of the sugar moieties mannose, fucose, and 
 
N
 
-acetylglucos-
amine by several of the eight C-type lectin domains within
the ectodomain of MR. Carbohydrate recognition domains
4–8 show affinity for natural ligands comparable to that of
MR itself (28). The phagocytic and endocytic activity is
mediated by a 45–amino acid cytoplasmic tail and trans-
membrane domain (20). MR also contains a cysteine-rich
domain (CR) with sequence similarity to the plant lectin
Ricin B at the NH
 
2
 
 terminus and an adjacent fibronectin
type II–like domain (29).
Our recent discovery of ligands of CR in mouse second-
ary lymphoid organs gave the first indication of a function
for CR, the domain of MR most highly conserved be-
tween mice and humans (30). Tissues were probed with a
chimeric probe consisting of CR fused to the Fc region of
human IgG1, CR-Fc. Binding of CR-Fc to spleen mar-
ginal metallophilic M
 
f
 
 and undefined cells in B cell areas,
and to lymph node subcapsular sinus M
 
f
 
, was observed in
naive animals, and a time–course study of a secondary im-
mune response indicated apparent migration of CR-bind-
ing cells from the subcapsular sinus to sites of developing
germinal centers. This suggested that MR could be directed
to areas where affinity maturation of B cells occurs. We have
recently purified ligands of CR-Fc from spleen and identi-
fied among these novel glycoforms of sialoadhesin (Sn) and
CD45 (Martínez-Pomares, L., our unpublished results).
We have also documented the existence of a soluble
form of MR (sMR) which may act as a mobile antigen
capture protein for delivery to the marginal zone of spleen
and lymph node subcapsular sinus, as well as to primary and
secondary B cell follicles (31). sMR is generated by proteoly-
sis of MR from cultured M
 
f
 
 and is shed into the media
where it retains calcium-dependent mannosyl binding activ-
ity. Immunoreactive sMR also occurs naturally in serum.
The roles of MR outlined above have all been assigned to
a functionally homogeneous MR, but Fiete and Baenziger
have recently revealed tissue heterogeneity in MR and a
new lectin activity of CR. They identified a receptor within
rat liver that recognizes and internalizes lutropin hormone
bearing Asn-linked oligosaccharides terminating in SO
 
4
 
-
4-GalNAc
 
b
 
1,4GlcNAc
 
b
 
1,2Man
 
a 
 
(S4GGnM), with struc-
tural and antigenic properties similar to MR, although MR
purified from lung did not recognize S4GGnM (32). A
protein with the same properties as this receptor could be
generated from the same cDNA as MR, and the ability to
bind galNAc-4-SO
 
4
 
 appeared to be determined posttrans-
lationally (33). The galNAc-4-SO
 
4
 
 binding site was then
localized to the CR by binding studies of deletion mutants
of MR (34).
In addition to heterogeneity within MR, a wider family
of molecules with the same basic structure as MR exists.
These are the phospholipase A2 receptors (35, 36), DEC-
205 (37, 38), and a novel lectin (39). Each has CR and fi-
bronectin type II–like domains, and either 8 or, in the case
of DEC-205, 10, C-type lectin-like domains.
More specific methods to detect in situ expression of
MR are required, given the heterogeneity of MR and the
limitations of ligand-binding assays. Several mAbs recog-
nizing human MR have recently been developed. Uccini
et al. (40) demonstrated MR expression in various reticulo-
endothelial tissues and in neoplasms of possibly endothelial
origin. MR was detected in resident tissue M
 
f
 
, including
those in spleen red pulp, lymph node paracortex, and thy-
mus cortex. Sinus lining cells of spleen and lymph node also
expressed MR and coexpressed M
 
f
 
 and endothelial mark-
ers. Noorman et al. (41) surveyed MR antigen in human
tissue, with broadly similar results. In mouse, Takahashi
and co-workers surveyed MR protein in a range of tissues
from fetal development to the adult, revealing expression
in M
 
f
 
 and some endothelial cells, although a precise def-
inition of most of these cell types was not attempted (42).
Given the heterogeneity of MR and the existence of
other MR family members, we studied expression of MR
in the normal adult mouse by both in situ hybridization
(ISH) and immunocytochemistry (ICC). In lymphoid or-
gans, we used double ICC to define the phenotype and lo-
cation of cells expressing MR. We compared MR with
markers of M
 
f
 
, DCs, and endothelium, and with the bind-
ing of CR-Fc. We found MR by ISH and ICC at identical
locations, in subsets of M
 
f
 
 and endothelium; no expression
was seen in Langerhans cells, other DCs, cells that express
putative CR ligands, or in sites in spleen and lymph node
that express mannosyl ligand binding activity. Cells at these
sites therefore may express novel MR-like receptor(s).
 
Materials and Methods
 
Animals.
 
BALB/c and sv/ev129 mice were bred at the Sir
William Dunn School of Pathology, and males and females were
used at 8–10 wk of age. 
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Abs and Fc Chimeric Protein.
 
Primary Abs used in this study
are described in Table I. MR polyclonal Abs raised against MR
purified from the J774e cell line and mAbs F4/80, FA.11, and
3D6 were prepared in-house. CR-Fc, a recombinant protein
consisting of the CR of mouse MR fused to the Fc region of hu-
man IgG1, was also prepared in our laboratory (30). The ERTR-9
mAb was a gift of Dr. C.D. Dijkstra (Free University, Amster-
dam, The Netherlands). Other Abs were purchased as shown.
N418 was biotinylated in-house for direct detection. The sec-
ondary Abs, biotinylated goat anti–rabbit IgG and biotinylated
rabbit anti–rat IgG, were purchased from Sigma Chemical Co.
Biotinylated mouse anti–human IgG (Fab
 
9
 
)
 
2
 
 was purchased from
Jackson ImmunoResearch Labs.
 
ICC.
 
Organs were collected and immersed in OCT com-
pound (BDH Chemicals-Merck) and frozen in dry ice–cooled
isopentane. Frozen sections were cut at 5 
 
m
 
m, air-dried for 1 h,
and stored at 
 
2
 
20
 
8
 
C. Before staining, slides were thawed at room
temperature for 30 min, then hydrated in PBS for 5 min at room
temperature followed by fixation for 10 min in 2% paraformalde-
hyde in Hepes-buffered isotonic saline at 4
 
8
 
C. The hydration step
was found to be essential for binding of anti-MR to tissues, and
avoids the requirement for protease treatment of sections de-
scribed by Takahashi and co-workers (42).
Fixed sections were washed in 0.1% (vol/vol) Triton X-100 in
PBS, and endogenous peroxidase activity was blocked with 10 mM
glucose, 1 mM NaN
 
3
 
, 0.4 U/ml glucose oxidase (Sigma Chemi-
cal Co.) in phosphate buffer for 15 min at 37
 
8
 
C. Blocking steps
used an avidin-biotin kit (Vector Laboratories) and a 30-min in-
cubation with 5% normal serum of the species in which the sec-
ondary Ab was raised. 5% serum was used as the diluent for pri-
mary and secondary Abs, with which the sections were incubated
for 60 and 30 min, respectively. Sections were then incubated
with avidin-biotin-peroxidase complex (ABC Elite; Vector Lab-
oratories). Peroxidase activity was finally detected with 0.5 mg/ml
3,3
 
9
 
-diaminobenzidine tetrahydrochloride (Polysciences, Inc.) and
0.024% H
 
2
 
O
 
2
 
 in 10 mM imidazole in PBS, pH 7.4. Sections
were counterstained with 0.1% cresyl violet or methyl green.
When double ICC was used to detect MR and other markers,
the first staining step with the above protocol was used, with the
substitution of 3-amino-9-ethylcarbazole (AEC) substrate kit for
diaminobenzidine (Vector Laboratories). In the second step, avidin-
biotin-alkaline phosphatase complex (ABC-AP) and Vector blue
detection system (Vector Laboratories) were used.
 
ISH.
 
The probe templates were generated by subcloning
regions of MR and Sn cDNA into pBS SK
 
1
 
/
 
2
 
, allowing sense
and antisense transcription from T3 and T7 promoters. The
301-bp SSt1-BamH1 fragment of MR corresponding to 922–
1223 bp of the cDNA and the 311- and 357-bp BamH1-BamH1
fragments of Sn corresponding to 765–1076 and 1076–1433 bp
of the cDNA, respectively, were chosen. 
 
35
 
S-labeled RNA probes
were transcribed from linearized plasmids using a Stratagene
RNA transcription kit. Probe was used at 3 
 
3 
 
10
 
6
 
 to 1 
 
3 
 
10
 
7
 
cpm/ml in 50% formamide, 10 mM Tris, pH 8.0, 300 mM
NaCl, 10 mM dithiothreitol, 100 mg/ml dextran sulphate, 200
g/ml Ficoll, 200 
 
m
 
g/ml polyvinylpyrrolidone, 200 
 
m
 
g/ml BSA,
and 500 
 
m
 
g/ml tRNA. Mouse tissue was prepared by perfusion-
fixation. After perfusion with heparinized physiological saline,
fixation was commenced with chilled 4% paraformaldehyde,
100 mM NaOH, 100 mM sodium acetate, pH 6.5 with acetic
acid, and followed by chilled 4% paraformaldehyde, 100 mM
NaOH, 100 mM sodium tetraborate, pH 9.5 with HCl. Dis-
sected organs were postfixed at 4
 
8
 
C in this latter fix for 3.5 h,
then placed in 20% sucrose in PBS for 16 h before freezing in
OCT compound over dry ice in isopentane. Tissues were sec-
tioned at 10 
 
m
 
m onto slides pretreated with Vectabond (Vector
Laboratories). Before hybridization, sections were rinsed in 100 mM
triethanolamine, pH 8.0, then treated by acetylation for 10 min with
2.5 
 
m
 
l/ml acetic anhydride in 100 mM triethanolamine, pH 8.0,
rinsed in 2
 
3
 
 SSC, and dehydrated through ethanol. Probe was
heated at 65
 
8
 
C for 10 min, spun at 4,000 rpm for 10 min, then
hybridized to tissue sections for 16 h at 56
 
8
 
C. Several posthybrid-
ization washes were performed, including a 30-min 20 
 
m
 
g/ml
RNAse A treatment, and high stringency washes for 30 min at
60
 
8
 
C in 0.1
 
3
 
 SSC, 1 mM dithiothreitol. Slides were exposed to
Ilford nuclear research emulsion for 10–17 d, and signal was de-
tected by Ilford PQ Universal paper developer diluted 1:4 with
distilled water and Unifix (Eastman Kodak Co.). Slides were
counterstained with 0.1% cresyl violet and photographed under
bright field microscopy.
 
Results
 
The specific recognition of MR may be hampered by
the tissue heterogeneity of MR, the potential cross-reactiv-
ity of reagents with other members of the family of proteins
with which it shares homology, and the existence of other
receptors that share a similar ligand recognition profile. We
 
Table I.
 
Antibodies Used in This Study
 
Antibody Isotype Murine antigen Reference/supplier
ERTR-9 Rat IgG Undefined antigen of marginal zone M
 
f
 
57
FA.11 Rat IgG2a Macrosialin 58
F4/80 Rat IgG2b F4/80 59
M5/114.15.2 Rat IgG2b I-A
 
b,d,k
 
, I-E
 
d,k
 
60
MR Rabbit polyclonal MR 61
NLDC-145 Rat IgG2a DEC-205 37
N418 Armenian hamster IgG CD11c 62
R6-60.2 Rat IgG2a IgM PharMingen
3D6 Rat IgG2a Sn 63
390 Rat IgG2a PECAM-1 (CD31) Serotec 
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have used two independent methods to detect MR specifi-
cally: ISH to define mRNA and therefore sites of synthesis,
and ICC to define protein expression in a wide range of
organs of normal adult mice. Specificity of mRNA detec-
tion was confirmed by performing control ISH with sense
strand probes. The specificity of the polyclonal anti-MR
Ab was examined by Western blotting of tissue lysates.
There was some tissue-specific heterogeneity with respect
to apparent molecular weight in the protein detected, but
in the absence of anti-MR, no signal was detected (not
shown). The treatment of tissues for ICC was mild, allow-
ing double ICC detection of MR with markers of M
 
f
 
, DCs,
and endothelium to define expression more closely. Of
particular interest, we used double ICC in lymphoid organs
to compare the expression of MR with that of the putative
CR ligand, Sn, and other ligands of CR-Fc.
 
MR Expression in Lymphoid Organs: MR and Sn Expression 
by ISH
Peripheral Lymph Node.
 
MR mRNA expression was seen
in the medullary cords (Fig. 1 A, arrow). The subcapsular si-
nus was clearly negative (Fig. 1 A, arrowhead), although this
site and the medulla were strongly labeled by the Sn probe
(Fig. 1 B). Control sections hybridized with sense probes of
MR (Fig. 1 C) and Sn had low background (Fig. 1 D). Al-
though Sn is expressed by medullary and subcapsular sinus
M
 
f
 
, only the latter bear ligands of CR-Fc (30). Together
these data clearly indicate that MR and its Sn ligand are not
produced concurrently in the lymph node.
 
Spleen.
 
MR expression was observed throughout the
red pulp by ISH, but appeared to be absent from the mar-
ginal zone and white pulp (Fig. 1 E). The marginal metal-
lophilic zone was readily identified by its high expression of
Sn (Fig. 1 F). The control sections for MR and Sn, respec-
tively, probed with sense strand RNAs, had no significant
background (Fig. 1, G and H). Although precise anatomi-
cal localization of the sites of synthesis was not possible by
this method, these data are highly suggestive of MR and Sn
synthesis occurring at distinct sites.
 
Thymus.
 
Discrete cells were labeled with MR probe
within the thymus (Fig. 1 I), with very little background in
the control (Fig. 1 J). Comparison with expression of Sn is
not informative, since thymic Sn is not a ligand of CR-Fc.
 
MR Expression in Lymphoid Organs: MR Expression by ICC; 
Comparison with Markers of DC, M
 
f
 
, and Endothelial Cells
Peripheral Lymph Node.
 
MR antigen was found on med-
ullary M
 
f
 
 (m), sinus lining M
 
f
 
, and endothelium of the
marginal sinus (ms), but not in T cell areas (t) (Fig. 2 A). No
detectable background staining was found in these areas in
the absence of MR Ab (Fig. 2 B). In contrast, DEC-205
was detected on interdigitating cells throughout the T cell
areas of an adjacent section (Fig. 2 C). By double ICC, Sn
and MR were shown to colocalize in medullary M
 
f
 
 (m)
(Fig. 3 A), but only Sn could be detected on the subcapsu-
lar sinus M
 
f
 
 (Fig. 3 A, arrow). By contrast, no colocaliza-
tion of CR-Fc and MR could be detected, CR-Fc being
confined to subcapsular sinus M
 
f
 
 and some germinal cen-
ter cells (Fig. 3 B, arrowhead). Scattered cells expressing
both MHCII and MR were detected in lymph nodes (Fig.
3 C) in the paracortex bordering the B cell follicle defined
by reactivity to anti-IgM (Fig. 3 D). These cells did not ex-
press DC markers DEC-205 or CD11c, nor did they ex-
press the M
 
f
 
 marker F4/80 (not shown). The elongated
morphology of MR staining cells and location in the mar-
Figure 1. Localization of MR and Sn mRNA in lymphoid organs by
ISH. (A) MR was expressed within the medulla of lymph node (arrow),
but is absent from the subcapsular sinus (arrowhead). (B) Sn expression
was also seen in the medulla of the lymph node, and additionally on the
subcapsular sinus. (C and D) Adjacent control sections hybridized with
sense orientation probes of MR and Sn, respectively, had low levels of
background. (E) MR is expressed by the red pulp of spleen. (F) In spleen,
Sn was abundantly expressed by the marginal zone, but was not detected
in red pulp above background levels. (G and H) Adjacent control spleen
sections hybridized with sense orientation MR and Sn probes, respec-
tively, had homogeneous levels of background throughout. (I) MR was
expressed by discrete cells of the thymus. (J) Background levels of hybrid-
ization of sense orientation probe were low in thymus. Bars 5 100 mm,
shown in A (for A–D), E (for E–H), and I (for I and J). 
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ginal sinus are characteristic of lymphatic endothelial cells,
but expression of MR was restricted to a CD31
 
2
 
 popula-
tion, indicating that high endothelial venules do not ex-
press MR (Fig. 3 E). MR
 
1
 
 endothelial cells (arrow) did not
coexpress the M
 
f
 
 marker macrosialin, detected with mAb
FA.11, although the intimately associated sinus lining M
 
f
 
(arrowhead) expressed both of these markers (Fig. 3 F).
Spleen. Single immunostaining of MR in spleen re-
vealed expression in red pulp (rp) Mf but not in the white
pulp (wp) or marginal zone (mz) (Fig. 2 D), while back-
ground staining in the absence of primary Ab was not de-
tected (Fig. 2 E). This is in contrast to the expression of
CD11c by DCs at the border of the white and red pulp
(Fig. 2 F) and other DC subsets of the white pulp that are
detectable with Abs to MHCII and DEC-205 (not shown).
Expression of Sn, a CR-Fc ligand in spleen, was compared
with that of MR by double ICC (Fig. 3 G). Sn alone was
detected in marginal metallophilic Mf, and there was addi-
tional low level expression in red pulp Mf along with strong
expression of MR. In contrast, CR-Fc bound to splenic
marginal metallophilic Mf, but not red pulp Mf (Fig. 3 H).
Therefore, MR and its putative ligand are expressed at
nonoverlapping sites, separated by a clear region in the
outer marginal zone. The absence of MR expression in this
Figure 2.  Localization of MR by ICC
and comparison with markers of DCs. (A)
In lymph node, MR was expressed by Mf
of the medulla (m) and sinus lining Mf, and
by endothelium of the marginal sinus (ms),
but not by cells of the T cell area (t). (B) In
the absence of MR Ab, background staining
was not detected. (C) DEC-205–expressing
DCs were abundant in the T cell area in
lymph node. (D) In spleen, MR was de-
tected in Mf and venous sinus endothelial
cells of the red pulp (rp), but appeared to be
absent from the marginal zone (mz) and
white pulp areas (wp). Central arteriole
staining was variable. (E) A control spleen
section had no background labeling. (F)
DCs expressing CD11c were prominent at
the border of the marginal zone with the
white pulp. (G) In thymus, MR immuno-
staining was prominent in Mf throughout
the cortex (c) and corticomedullary junction
(cmj). Mf of the medulla appeared to be
negative for MR or to express very low lev-
els (m). (H) In the absence of MR Ab,
background staining in thymus was absent.
(I) DEC-205 was detected on cortical epi-
thelial cells and medullary interdigitating
cells. (J) In Peyer’s patch, MR expression
was confined to lymphatic endothelium in
the interfollicular areas (i), but was absent
from follicles (f). (K) In contrast, FA.11
staining was detected in Mf and DCs of the
follicles and interfollicular areas, but was ab-
sent from endothelial cells. (L) In skin, MR
was expressed by dermal Mf, but epidermal
Langerhans cell staining was not detected.
(M) F4/80 was expressed by both dermal
Mf and epidermal Langerhans cells (arrow)
of the skin. Bars 5 50 mm, shown in A (for
A–F), G (for G–I), J (for J and K), and L (for
L and M).1966 Expression of Mannose Receptor in Mouse
Figure 3. Localization of MR
with respect to markers of Mf
and endothelium by double ICC
staining. MR was defined by a
red product and the additional
marker by blue. (A) There was
some colocalization of MR with
Sn, in the medullary Mf of the
lymph node (m), but Sn was also
detected in MR2 cells of the
subcapsular sinus (arrow). (B) In
lymph node, there was no colo-
calization between MR and
CR-Fc, the latter staining only
subcapsular sinus Mf and a few
cells in B cell follicles (arrow-
head). (C) Scattered MR1 cells
also express MHCII, and are lo-
cated (D) in the paracortex adja-
cent to the B cell follicle defined
by expression of IgM. (E) The
endothelial cells that express MR
in lymph node do not also ex-
press CD31, showing that only
lymphatic endothelium and not
high endothelial venules express
MR. (F) These MR1 endothe-
lial cells (arrow) do not coexpress
macrosialin, although the inti-
mately associated sinus lining
Mf express both markers (ar-
rowhead). (G) In spleen, Sn was
highly expressed by the marginal
metallophilic Mf and by mar-
ginal zone Mf, and at low levels
by red pulp Mf which are
strongly MR1. (H) As in lymph
node, MR and CR-Fc defined
two distinct populations in
spleen. CR-Fc was localized in
the marginal metallophilic Mf
and B cell areas of the white
pulp, separated from the MR1
red pulp Mf by the unlabeled
outer marginal zone. (I) The
boundary of the splenic marginal
zone with the red pulp was de-
fined by the marginal zone Mf
marker, ERTR-9. MR was ab-
sent from this population of Mf,
so its expression is restricted to
the red pulp. (J) Spleen red pulp
Mf were stained with both anti-
MR and FA.11, whereas the
MR1 venous endothelium did
not react with FA.11 (arrow).
(K) In thymus, the majority of
MR1 cells coexpressed the Mf
marker F4/80. (L) Staining of
MR and CR-Fc in thymus re-
vealed two distinct populations.
CR-Fc was bound by large un-
defined cells of the medulla that
may be part of the thymic epi-
thelium, whereas MR appeared
restricted to Mf and possibly
endothelium. Bars 5 50 mm,
shown in A (for A and B), C–F,
G (for G and H), I (for I–K),
and L.1967 Linehan et al.
compartment was confirmed by double staining with
ERTR-9, an mAb that specifically recognizes Mf of the
outer marginal zone (Fig. 3 I). Double ICC for MR and
macrosialin with FA.11 defined two subsets of MR1 cells,
double-positive Mf (Fig. 3 J), and elongated venous sinus
endothelial cells which did not express macrosialin (Fig. 3 J,
arrow).
Thymus. ICC revealed two distinct populations of cells
that express MR. These were highly stained flattened Mf
lying beneath the capsule and along the connective tissue
septa that penetrate the cortex (not shown), and less in-
tensely stained Mf with fine processes that were found
throughout the cortex (c) and the corticomedullary junc-
tion (cmj) (Fig. 2 G). Staining of Mf in the medulla (m)
was very weak or negative (Fig. 2 G). A control section did
not reveal any detectable background staining (Fig. 2 H).
Cells expressing MR were quite distinct from the DEC-
205–expressing cortical epithelial cells which have exten-
sive dendrites, and the few rounded interdigitating cells of
the medulla (Fig. 2 I). It seems likely that all MR1 cells in
the thymus are Mf. By double ICC it is apparent that most
of them coexpress the Mf marker, F4/80 (Fig. 3 K). As in
spleen and lymph node, double staining with CR-Fc in
thymus revealed that MR and CR-Fc ligand(s) are ex-
pressed by two distinct populations of cells (Fig. 3 L). CR-
Fc bound to large undefined cells of the medulla which may
be part of the thymic epithelium.
Peyer’s Patch. MR antigen appeared to be confined to
the lymphatic endothelium of interfollicular areas (i) and
was notably absent in follicles (f) (Fig. 2 J). Mf and DCs in
the interfollicular areas and follicles of an adjacent section
that were identified with FA.11 did not express MR (Fig.
2 K). Control sections of Peyer’s patch gave no background
signal (not shown).
Skin. MR was detected in dermal Mf, but not in epi-
dermal Langerhans cells (Fig. 2 L). In contrast, F4/80
stained both Mf (Fig. 2 M) and Langerhans cells (Fig. 2 M,
arrow). Again, no nonspecific staining was seen in control
sections (not shown). We could not detect MR in isolated
epidermal sheets of normal mice, using either the ICC
method presented here, or the method of Takahashi and
co-workers (42; data not shown).
MR Expression in Nonlymphoid Organs
We confirmed by ISH and ICC previous studies demon-
strating expression of MR in hepatic endothelium and Mf
of liver (Kupffer cells), gut, lung, and resident tissue Mf of
other organs (not shown). We describe here the novel find-
ing of MR in perivascular microglia of brain and glomeru-
lar mesangial cells of kidney.
Brain. Mf and related cells of the brain perform spe-
cialized functions in tissue homeostasis, inflammation, and
maintenance of the blood–brain barrier. They are pheno-
typically, functionally, and morphologically distinct, and
thus deserve special attention in their expression of MR. In
addition, previous studies have suggested a role for an MR
on vascular endothelium in regulating blood–brain barrier
function. We observed that meningeal Mf express MR by
ISH (Fig. 4 A) and ICC (not shown). Perivascular micro-
glia also express MR, but adjacent vessel endothelium does
not, as shown by ISH (Fig. 4 B) and ICC (Fig. 4 C). Con-
firmation that these cells are perivascular microglia was de-
duced from their expression of F4/80 (Fig. 4 D). No signal
was detected in the meninges or brain parenchyma in con-
trol sections examined by ISH or ICC (not shown). Like
perivascular microglia, astrocytes are also associated with
vessels, whereas more differentiated microglia are deeper in
the parenchyma. Neither of these cell types appeared to ex-
press MR in normal brain (Fig. 4, B and C).
Kidney. MR was observed in kidney glomeruli, both
by ISH (Fig. 5 A) and ICC (Fig. 5 B) in repeated experi-
ments. Control sections for ISH (Fig. 5 C) and ICC (Fig. 5 D)
have low background, verifying the authenticity of these
observations. An example of a glomerulus stained for MR
and observed at high magnification indicated that expres-
sion is present on the mesangial cells (Fig. 5 E). No expres-
Figure 4. Expression of MR in brain. (A)
MR was detected in meningeal Mf by
ISH, here shown within an infolding of the
meninges into the cerebellum. (B) By ISH,
MR was detected in cells adjacent to blood
vessels, the perivascular microglia. (C) ICC
revealed expression of MR protein in
perivascular microglia. (D) Expression of F4/
80 by perivascular microglia confirmed that
these cells were Mf. Bars 5 50 mm, shown
in A (for A and B) and C (for C and D).1968 Expression of Mannose Receptor in Mouse
sion of Mf markers F4/80, FA.11, or Sn was observed on
glomeruli, nor did they bind CR-Fc (not shown).
Discussion
We have used two independent methods to examine the
expression of MR mRNA and protein in normal adult
mouse. In all tissues studied, sites of synthesis of mRNA,
examined by ISH, and expression of antigen, detected by
ICC, were identical, suggesting that protein transfer between
cells did not contribute to the staining observed. Both meth-
ods demonstrated MR expression by subsets of Mf and en-
dothelial cells. We confirmed previous studies of mature
Mf labeling in mice (42) and humans (40, 41), although a
closer analysis of Mf in spleen and lymph node revealed an
unexpected anomaly. An MR-like binding activity has been
described on marginal zone Mf in mouse (16) and rat (15)
spleen. Similarly, the subcapsular sinus Mf of the lymph
node have also been documented as having an MR-like
binding activity in mice (14) and rats (15), although no spe-
cific carbohydrate receptor has been characterized structur-
ally or antigenically in either case. Here we demonstrate
clearly that MR is not responsible for these activities. Dou-
ble ICC staining of MR with the marginal zone Mf
marker ERTR-9 confirmed that the cells of the marginal
zone do not express MR. Similarly, we did not detect MR
on subcapsular sinus Mf by ISH or ICC. These binding
activities, which are described as calcium dependent and of
high affinity for ligands such as a linear b-1,2–linked tetra-
mannose from C. albicans (16), Trypanosoma cruzi amasti-
gotes (14), mannose/fucose/N-acetylglucosamine-BSA (15),
and mannan (43) must therefore be mediated by some ad-
ditional unknown receptor(s).
We found endothelium to be heterogeneous with respect
to expression of MR. MR was detected on endothelial cells of
spleen red pulp and liver, whereas blood vessel and high endo-
thelial cells were negative. However, lymphatic endothelium
appeared to express MR widely, consistent with a constitutive
function, possibly endocytosis. Our finding contrasts with that
in humans, in which lymphatic endothelium appeared nega-
tive, although coexpression of MR with endothelial markers
CD31, VE-cadherin, and von Willebrand factor was observed
in sinus lining cells of the spleen and lymph node (40). There
may be additional phenotypic differences between human and
murine endothelial cells. In contrast to humans, we noted the
absence of CD31 expression by lymphatic endothelium and
sinus lining cells of murine lymph node. Further studies are
needed to establish the functional significance of heterogeneity
in MR expression by selected vascular and lymphatic endo-
thelium in different species.
MR has been implicated in T cell immunity, after the
discovery of its expression on cultured human blood mono-
cyte–derived DCs (24) and on DCs expanded from cord
blood hemopoietic progenitors (11). Isolated DCs use MR
to endocytose mannosylated ligands for presentation to T
cells by MHCII (24) and CD1b (27). MR-mediated anti-
gen uptake confers a greatly enhanced efficiency of presen-
tation to T cells, of the order of 100 (25) and 200–10,000-
fold (26). MR may be a marker of immature DCs, since it
is downregulated  in vitro by inflammatory stimuli (10).
However, we found no expression of MR on DCs in vivo
in thymus, lymph node, spleen, and Peyer’s patch of nor-
mal mice. In particular, the CD11c1 cells of the spleen,
which are thought to represent an immature population of
Figure 5. MR is expressed by renal
glomerular mesangial cells. (A) Clusters of
cells in the outer cortex of the kidney were
detected by ISH using MR anti-sense
probe. (B) By ICC, clusters of cells express-
ing MR were more easily determined to be
within glomeruli. (C) A control section hy-
bridized with MR sense probe showed no
specific binding. (D) Similarly, a control
section treated without MR Ab had low
background staining, and none associated
with glomeruli. (E) A single glomerulus
stained for MR is shown at higher magnifi-
cation, showing expression of MR on me-
sangial cells. Bars 5 100 mm, shown in A
(for A – D), and 50 mm, shown in E.1969 Linehan et al.
myeloid-derived DCs, did not express MR. Likewise, we
did not observe expression of MR by resting Langerhans
cells of skin epidermis. This observation is consistent with
the study by Reis e Sousa et al. (12), in which MR could
not be detected on lysates of purified murine Langerhans
cells by Western blotting, although a mannose-specific up-
take by these cells was identified. Similarly, ICC studies in
human tissue did not detect expression of MR in Langer-
hans cells (40, 41), although freshly isolated Langerhans cells
did express functional MR (13). We did detect a subpopula-
tion of MR1 cells of lymph nodes in the T cell areas border-
ing the B cell follicles which express MHCII, but these are
unlikely to represent a known population of DCs, as they
did not express DEC-205 or CD11c (not shown). Further
studies are required to determine whether MR is expressed
by DCs after immunization, and to characterize the man-
nose-specific binding activity of Langerhans cells, which may
be due to a distinct receptor. The apparent lack of expression
of MR on resting murine DCs in situ should be cautionary
for those working on cultured DC populations.
We compared expression of MR with that of the putative
endogenous ligand(s) of the CR, those that bind CR-Fc.
Previously we hypothesized that a soluble form of MR or
MR1 cells may interact with CR-Fc binding cells of spleen
marginal metallophilic Mf, lymph node subcapsular sinus
Mf, and germinal center cells (31). This would allow
transfer of MR-bound carbohydrate antigen to cells strategi-
cally positioned at sites of generation of B cell responses to
carbohydrate antigens. Here, we show that cells that bind
CR-Fc in spleen and lymph node do not coexpress MR; in-
deed, the receptor and the ligand(s) are at spatially distinct
sites within these organs, consistent with a transfer function
via sMR. Although we did not detect sMR bound to the
subcapsular sinus Mf or marginal metallophilic Mf, it may
be present at levels below detection or may depend on im-
mune stimulation. Intriguingly, we also observed scattered
CR-Fc binding cells in the thymic medulla, where a role in
capture of antigen-laden sMR would be unexpected. Thy-
mic epithelial cells synthesize a variety of glycoprotein hor-
mones (44), and our recombinant protein may recognize one
of these in the thymus. Our CR-Fc, like the CR-Fc prepared
by Fiete and co-workers (34), binds to bovine lutropin hor-
mone, a glycoprotein bearing terminal galNAc-4-SO4 (Line-
han, S.A., and L. Martínez-Pomares, unpublished data).
We have made a wider survey of MR expression than
had previously been undertaken, including brain and kid-
ney. We identified MR expression in perivascular micro-
glia of murine brain by ISH and ICC. Perivascular micro-
glia lie on the parenchymal side of arterioles, and MR at
this location may be appropriately placed to endocytose
glycoproteins that have traversed the blood–brain barrier.
These specialized Mf also express class A scavenger recep-
tors and take up modified low density lipoprotein injected
into the blood or cerebral ventricles (45). Those authors
also showed that horseradish peroxidase, a known ligand of
MR, can be endocytosed by perivascular microglia (45). In
another study, liposomes labeled with mannose passed
through the murine blood–brain barrier more efficiently
than those labeled with fucose or galactose (46). Similarly,
the ependymal cell layer lining the cerebral ventricles regu-
lates solute transport between the cerebrospinal fluid and
brain tissue, and in rat this can be dissociated by mannose-
but not glucose- or galactose-BSA (47). However, we
found that neither the ependymal cells nor the endothelial
cells of the blood–brain barrier expressed MR. Astrocytes
and more differentiated microglia of the parenchyma do
not express MR in normal brain. Both of these cell types
have a tendency to upregulate various Mf markers when
cultured in vitro or stimulated in vivo, so a definitive study
of their phenotype requires further in situ analysis.
We also demonstrated expression of both MR mRNA
and protein in glomerular mesangial cells of the kidney in
situ. The glomerulus is the site at which blood is first fil-
tered in the kidney. MR mRNA and protein have been
observed on in vitro–cultured mouse mesangial cells stimu-
lated with the inflammatory cytokines TNF-a and IL-1a,
but were absent from unstimulated cells (48). An endocytic
role for MR on mesangial cells is consistent with clearance
of the MR ligand COOH-terminal propeptide of type 1
procollagen labeled with nondegradable 125I-tyramine-cel-
lobiose, in which 20% of the label was found in the kidneys
while 70% was recovered from liver (49). Glomerular me-
sangial cells share some features of the reticulo-endothelial
system, including the ability to phagocytose apoptotic cells
(50, 51). Cultured human mesangial cells also express com-
ponents of NADPH oxidase (52) and FcgRIII and FceRIg
chain (53). However, murine mesangial cells lacked all of the
Mf markers used in this study apart from MR (not shown),
and are not believed to share a common lineage with he-
mopoietic and endothelial cells, which can both be gener-
ated from embryonic mesodermal cells (54, 55). Another cell
type that is not hemopoietic or endothelial, but has been re-
ported to express MR, is retinal pigment epithelium (7). Al-
though the expression of MR in myeloid cells appears to be
regulated by the transcription factors PU.1 and Sp1 (56), the
detection of MR in mesangial cells and retinal pigment epi-
thelium suggests that other transcription factors must be in-
volved in these distantly related cell types.
In conclusion, we have characterized murine MR ex-
pression in situ in subsets of Mf and endothelial cells, but
not DCs, describing novel expression in perivascular mi-
croglia and renal mesangial cells. We demonstrate that
MR-like binding activities of spleen marginal zone Mf
and lymph node subcapsular sinus Mf, and possibly
Langerhans cells, in situ are not due to MR. The expres-
sion pattern of MR in lymphoid organs is consistent with a
model of antigen capture by MR and transfer to sites of
anticarbohydrate immunity by a soluble form of MR that
may recognize cells at these sites by their expression of
ligands of the cysteine-rich domain of MR. Overall, the MR
is widely expressed by distinct cell types involved in poten-
tial clearance functions. Further studies are needed to in-
vestigate the regulation of MR expression by these cells
and the posttranslational modification of MR protein in
different tissue microenvironments, as well as to character-
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